These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33361146)

  • 1. Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes.
    Potier L; Hansel B; Larger E; Gautier JF; Carreira D; Assemien R; Lantieri O; Riveline JP; Roussel R
    Diabetes Care; 2021 Mar; 44(3):839-843. PubMed ID: 33361146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
    Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
    J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes.
    Caruso I; Di Molfetta S; Guarini F; Giordano F; Cignarelli A; Natalicchio A; Perrini S; Leonardini A; Giorgino F; Laviola L
    Diabetes Metab Res Rev; 2021 Sep; 37(6):e3404. PubMed ID: 32918324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
    Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
    An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic.
    Ali N; El Hamdaoui S; Nefs G; Tack CJ; De Galan BE
    BMJ Open Diabetes Res Care; 2022 May; 10(3):. PubMed ID: 35606020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
    Garofolo M; Aragona M; Rodia C; Falcetta P; Bertolotto A; Campi F; Del Prato S; Penno G
    Diabetes Res Clin Pract; 2021 Oct; 180():109066. PubMed ID: 34563586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
    Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
    Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
    Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA
    BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes.
    Shah N; Karguppikar M; Bhor S; Ladkat D; Khadilkar V; Khadilkar A
    J Pediatr Endocrinol Metab; 2021 Feb; 34(2):217-223. PubMed ID: 33185578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
    Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
    Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
    Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.
    Salabelle C; Ly Sall K; Eroukhmanoff J; Franc S; Oumbiche H; Zrafi WS; Dang Duy TL; Valentim C; Gaston F; Fernandes S; Faucherand M; Penfornis A; Amadou C
    Prim Care Diabetes; 2021 Oct; 15(5):884-886. PubMed ID: 34257050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study.
    Di Dalmazi G; Maltoni G; Bongiorno C; Tucci L; Di Natale V; Moscatiello S; Laffi G; Pession A; Zucchini S; Pagotto U
    BMJ Open Diabetes Res Care; 2020 Oct; 8(2):. PubMed ID: 33115820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of diabetes home control in COVID-19 times: Proof is in the pudding.
    Cotovad-Bellas L; Tejera-Pérez C; Prieto-Tenreiro A; Sánchez-Bao A; Bellido-Guerrero D
    Diabetes Res Clin Pract; 2020 Oct; 168():108379. PubMed ID: 32853692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
    Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
    Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
    [No Abstract]   [Full Text] [Related]  

  • 19. Type 1 diabetes and COVID-19: The "lockdown effect".
    Aragona M; Rodia C; Bertolotto A; Campi F; Coppelli A; Giannarelli R; Bianchi C; Dardano A; Del Prato S
    Diabetes Res Clin Pract; 2020 Dec; 170():108468. PubMed ID: 32987040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring.
    Dover AR; Ritchie SA; McKnight JA; Strachan MWJ; Zammitt NN; Wake DJ; Forbes S; Stimson RH; Gibb FW
    Diabet Med; 2021 Jan; 38(1):e14374. PubMed ID: 32740984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.